Acute Myeloid Leukemia With Myelodysplasia-Related Changes

DBCOND0036177Hemic and Lymphatic Diseases Neoplasms

Acute Myeloid Leukemia With Myelodysplasia-Related Changes is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Classified under: Hemic and Lymphatic Diseases
Neoplasms
Indicated drugs: Cytarabine
Daunorubicin

Resolves to

Vocabularies

SNOMED CT128827005UMLSC2825139

What you can answer from here — as of November 01, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

7Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Acute Myeloid Leukemia With Myelodysplasia-Related Changes share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account